JP2007532577A - 塩基性浸透促進剤と共に用いるための経皮デリバリー・システム - Google Patents

塩基性浸透促進剤と共に用いるための経皮デリバリー・システム Download PDF

Info

Publication number
JP2007532577A
JP2007532577A JP2007507560A JP2007507560A JP2007532577A JP 2007532577 A JP2007532577 A JP 2007532577A JP 2007507560 A JP2007507560 A JP 2007507560A JP 2007507560 A JP2007507560 A JP 2007507560A JP 2007532577 A JP2007532577 A JP 2007532577A
Authority
JP
Japan
Prior art keywords
drugs
active substance
hydrophilic polymer
hydroxide
insoluble hydrophilic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007507560A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007532577A5 (https=
Inventor
ス，ツン−ミン
ジャコブソン，エリック
シー． ルオ，エリック
ティー．ジェイ． ヒッキー，アラン
ティー． グリケンコ，ニコル
Original Assignee
ダーマトレンズ，インコーポレイティド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ダーマトレンズ，インコーポレイティド filed Critical ダーマトレンズ，インコーポレイティド
Publication of JP2007532577A publication Critical patent/JP2007532577A/ja
Publication of JP2007532577A5 publication Critical patent/JP2007532577A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2007507560A 2004-04-07 2005-04-07 塩基性浸透促進剤と共に用いるための経皮デリバリー・システム Pending JP2007532577A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56049904P 2004-04-07 2004-04-07
PCT/US2005/012163 WO2005099676A2 (en) 2004-04-07 2005-04-07 Transdermal delivery system for use with basic permeation enhancers

Publications (2)

Publication Number Publication Date
JP2007532577A true JP2007532577A (ja) 2007-11-15
JP2007532577A5 JP2007532577A5 (https=) 2008-05-22

Family

ID=35150487

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007507560A Pending JP2007532577A (ja) 2004-04-07 2005-04-07 塩基性浸透促進剤と共に用いるための経皮デリバリー・システム

Country Status (6)

Country Link
US (1) US20080138390A1 (https=)
EP (1) EP1744714A4 (https=)
JP (1) JP2007532577A (https=)
CA (1) CA2564341A1 (https=)
IL (1) IL178499A0 (https=)
WO (1) WO2005099676A2 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011516166A (ja) * 2008-03-31 2011-05-26 アルテア セラピューティクス コーポレイション 浸透物送達システム及びその使用方法
JP2020532558A (ja) * 2017-09-04 2020-11-12 エルテーエス ローマン テラピー−ジステーメ アーゲー 乳化剤を含む経皮送達システム

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9169279B2 (en) 2009-07-31 2015-10-27 Thar Pharmaceuticals, Inc. Crystallization method and bioavailability
US20160016982A1 (en) 2009-07-31 2016-01-21 Thar Pharmaceuticals, Inc. Crystallization method and bioavailability
CA2769633C (en) 2009-07-31 2017-06-06 Thar Pharma, Llc Crystallization method and bioavailability
WO2012071517A2 (en) 2010-11-24 2012-05-31 Thar Pharmaceuticals, Inc. Novel crystalline forms
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US8633178B2 (en) 2011-11-23 2014-01-21 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20160199316A1 (en) 2013-06-14 2016-07-14 Tesa Labtec Gmbh Three-layer transdermal therapy system (tts)
DE102014000200A1 (de) 2014-01-03 2015-07-09 Michael Horstmann Transdermales Therapeutisches System
JP6173491B2 (ja) * 2014-01-31 2017-08-02 久光製薬株式会社 エメダスチン含有テープ剤
US9468606B2 (en) * 2014-03-31 2016-10-18 Johnson & Johnson Consumer Inc. Compostions and methods for enhancing the topical application of an acidic benefit agent
EP3145489A1 (en) 2014-05-22 2017-03-29 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
WO2017208070A1 (en) 2016-05-31 2017-12-07 Grünenthal GmbH Bisphosphonic acid and coformers with lysin, glycin, nicotinamide for treating psoriatic arthritis

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0413617A (ja) * 1990-04-27 1992-01-17 Sekisui Chem Co Ltd 貼付剤
JPH0912448A (ja) * 1995-04-28 1997-01-14 Read Chem Kk 薬物放出制御型経皮吸収製剤
JPH10306023A (ja) * 1997-05-06 1998-11-17 Sekisui Chem Co Ltd 経皮吸収製剤及びその製造方法
US6303700B1 (en) * 1997-04-30 2001-10-16 Coloplast A/S Adhesive agent and use of such adhesive agent
JP2002536403A (ja) * 1999-02-10 2002-10-29 イエナフアルム ゲーエムベーハー ウント ツェーオー． カーゲー 経皮系のための作用物質含有ラミネート
JP2004500360A (ja) * 1999-12-16 2004-01-08 ダーマトレンズ，　インコーポレイテッド 皮膚浸透促進剤としての水酸化物放出剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
SG59962A1 (en) * 1989-11-03 1999-02-22 Riker Laboratories Inc Bioadhersive composition and patch
US6558695B2 (en) * 1999-12-16 2003-05-06 Dermatrends, Inc. Topical and transdermal administration of peptidyl drugs using hydroxide releasing agents as permeation enhancers
US20020192242A1 (en) * 1999-12-16 2002-12-19 Tsung-Min Hsu Transdermal and topical administration of bone density regulators using basic enhancers
US6565879B1 (en) * 1999-12-16 2003-05-20 Dermatrends, Inc. Topical and transdermal administration of peptidyl drugs with hydroxide-releasing agents as skin permeation enhancers
US6586000B2 (en) * 1999-12-16 2003-07-01 Dermatrends, Inc. Hydroxide-releasing agents as skin permeation enhancers

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0413617A (ja) * 1990-04-27 1992-01-17 Sekisui Chem Co Ltd 貼付剤
JPH0912448A (ja) * 1995-04-28 1997-01-14 Read Chem Kk 薬物放出制御型経皮吸収製剤
US6303700B1 (en) * 1997-04-30 2001-10-16 Coloplast A/S Adhesive agent and use of such adhesive agent
JPH10306023A (ja) * 1997-05-06 1998-11-17 Sekisui Chem Co Ltd 経皮吸収製剤及びその製造方法
JP2002536403A (ja) * 1999-02-10 2002-10-29 イエナフアルム ゲーエムベーハー ウント ツェーオー． カーゲー 経皮系のための作用物質含有ラミネート
JP2004500360A (ja) * 1999-12-16 2004-01-08 ダーマトレンズ，　インコーポレイテッド 皮膚浸透促進剤としての水酸化物放出剤

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011516166A (ja) * 2008-03-31 2011-05-26 アルテア セラピューティクス コーポレイション 浸透物送達システム及びその使用方法
JP2020532558A (ja) * 2017-09-04 2020-11-12 エルテーエス ローマン テラピー−ジステーメ アーゲー 乳化剤を含む経皮送達システム
JP7212676B2 (ja) 2017-09-04 2023-01-25 エルテーエス ローマン テラピー－ジステーメ アーゲー 乳化剤を含む経皮送達システム
US12383509B2 (en) 2017-09-04 2025-08-12 Lts Lohmann Therapie-Systeme Ag Transdermal delivery system including an emulsifier

Also Published As

Publication number Publication date
WO2005099676A2 (en) 2005-10-27
WO2005099676A3 (en) 2006-04-27
IL178499A0 (en) 2007-02-11
US20080138390A1 (en) 2008-06-12
EP1744714A4 (en) 2009-08-26
CA2564341A1 (en) 2005-10-27
EP1744714A2 (en) 2007-01-24

Similar Documents

Publication Publication Date Title
JP2007532577A (ja) 塩基性浸透促進剤と共に用いるための経皮デリバリー・システム
CN1835722B (zh) 激素透皮递送系统:组合物和方法
US9005653B2 (en) Transdermal delivery of hormones with low concentration of penetration enhancers
CN1042075A (zh) 含有孕二烯酮的透皮应用的药剂
HUT75159A (en) Percutaneously absorbable preparation, containing 3-ketodesogestrel and 17 beta-estradiol
JP2011513287A (ja) 医薬品組成物
TW200425916A (en) Microreservoir system based on polysiloxanes and ambiphilic solvents
JP2005528356A (ja) 改善された粘着力を有する酢酸ビニル−ビニルピロリドン共重合体に基づく活性物質貯留部を備えた、ホルモン含有経皮治療システム
WO2007029781A1 (ja) ビソプロロール含有貼付製剤
EP1541137B1 (en) Transdermal delivery system of gestodene
JP2001213768A (ja) パップ剤
WO2005060540A2 (en) Norethindrone sustained release transdermal formulation
JP6345120B2 (ja) 経皮ホルモン送達
CZ2002488A3 (cs) Transdermální podávání lasofoxifenu
JP2503095B2 (ja) 貼付剤
WO2005058287A2 (en) Transdermal delivery system of hormones without penetration enhancers
CA3236288A1 (en) Occlusive plaster with flexible backing
WO2014068600A1 (en) Stable transdermal pharmaceutical drug delivery system comprising diclofenac
WO1998046267A1 (fr) Composition de base pour absorption percutanee, preparation destinee a cette absorption et renfermant ladite composition
JP3295735B2 (ja) エストリオール経皮投与貼付剤
JPH05186371A (ja) 経皮吸収製剤
JP2005528432A (ja) ノルエチンドロン徐放処方物およびそれに関連する方法
TWI298253B (en) Transdermal delivery of lasofoxifene
JP2001002588A (ja) 経皮エストロゲンアゴニスト・アンタゴニスト療法
JP2844262B2 (ja) エストラジオール経皮投与製剤

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080407

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080407

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110628

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20120124